secwatch.observer — SEC 8-K summary
======================================

Issuer:     bioAffinity Technologies, Inc. (BIAF)
CIK:        0001712762
Form:       8-K
Filed at:   2026-02-19T23:59:59+00:00
Accession:  0001493152-26-007464
Event type: other_material
Sentiment:  positive
Materiality: 0.40
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

bioAffinity Technologies releases case study showing CyPath Lung helps avoid biopsy in elderly patient
--------------------------------------------------------------------------------

- CyPath Lung test was negative for a 79-year-old woman with suspicious LDCT finding, supporting surveillance over invasive biopsy.
- Repeat CT scan in October 2025 showed nodule resolved, validating the conservative management decision.
- Test demonstrated 92% sensitivity, 87% specificity, and 88% accuracy for detecting lung cancer in nodules <2 cm.
- Case study highlights CyPath Lung's role in reducing unnecessary procedures in high-risk patients.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1712762/000149315226007464/0001493152-26-007464-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1712762/000149315226007464/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-007464

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer